GSK Aktie
21,52
EUR
-0,05
EUR
-0,23
%
19,87
CHF
-0,18
CHF
-0,90
%
Werbung
GSK Aktie Analyse
| 18.07.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 17.07.25 | GSK Neutral | UBS AG | |
| 15.07.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 15.07.25 | GSK Hold | Deutsche Bank AG | |
| 10.07.25 | GSK Neutral | UBS AG | |
| 03.07.25 | GSK Neutral | UBS AG | |
| 01.07.25 | GSK Neutral | UBS AG | |
| 30.06.25 | GSK Neutral | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 30.06.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 10.06.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 04.06.25 | GSK Outperform | Bernstein Research | |
| 03.06.25 | GSK Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.05.25 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.05.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 14.05.25 | GSK Hold | Deutsche Bank AG | |
| 14.05.25 | GSK Neutral | Goldman Sachs Group Inc. | |
| 12.05.25 | GSK Hold | Deutsche Bank AG | |
| 01.05.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.05.25 | GSK Neutral | Goldman Sachs Group Inc. | |
| 01.05.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.05.25 | GSK Neutral | UBS AG | |
| 30.04.25 | GSK Neutral | UBS AG | |
| 30.04.25 | GSK Hold | Jefferies & Company Inc. | |
| 30.04.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 22.04.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 07.04.25 | GSK Hold | Deutsche Bank AG | |
| 04.04.25 | GSK Hold | Deutsche Bank AG | |
| 03.04.25 | GSK Outperform | Bernstein Research | |
| 28.03.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 25.03.25 | GSK Hold | Deutsche Bank AG | |
| 20.02.25 | GSK Outperform | Bernstein Research | |
| 17.02.25 | GSK Neutral | Goldman Sachs Group Inc. | |
| 10.02.25 | GSK Hold | Deutsche Bank AG | |
| 07.02.25 | GSK Outperform | Bernstein Research | |
| 07.02.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 07.02.25 | GSK Neutral | Goldman Sachs Group Inc. | |
| 06.02.25 | GSK Hold | Deutsche Bank AG | |
| 06.02.25 | GSK Neutral | UBS AG | |
| 05.02.25 | GSK Neutral | Goldman Sachs Group Inc. | |
| 05.02.25 | GSK Outperform | Bernstein Research | |
| 05.02.25 | GSK Neutral | UBS AG | |
| 05.02.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.01.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.01.25 | GSK Neutral | UBS AG | |
| 20.01.25 | GSK Hold | Jefferies & Company Inc. | |
| 15.01.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 10.01.25 | GSK Hold | Deutsche Bank AG | |
| 07.01.25 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.01.25 | GSK Outperform | Bernstein Research | |
| 18.12.24 | GSK Hold | Deutsche Bank AG | |
Werbung
Werbung